Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

Queen's University at Kingston

🇨🇦Canada

Country: 🇨🇦Canada

Ownership: Private

Established: 1841-10-16

Employees: 1K

Market Cap: -

Website: http://www.queensu.ca

Clinical Trials

Inspiratory Muscle Training for Breathless Patients With Chronic Obstructive Pulmonary Disease and Heart Failure

Phase 4

Conditions: Pulmonary Disease, Chronic Obstructive
Heart Failure, Systolic

Interventions: Device: POWERbreathe®KHA (IMT group)
Device: POWERbreathe®KH2 (sham group)

First Posted Date: 2015-10-19

Last Posted Date: 2016-10-18

Lead Sponsor: Queen's University

Target Recruit Count: 50

Registration Number: NCT02579200

Locations: 🇧🇪
KU Leuven, Leuven, Belgium
🇧🇷
Universidade Federal do Rio Grande do Sul/Hospital de Clínicas de Porto Alegre, Porto Alegre, RS, Brazil
🇧🇷
Universidade Federal de São Paulo, Sao Paulo, SP, Brazil

Hati Salama (Secure Voucher)

Not Applicable

Completed

Conditions: Malaria

Interventions: Behavioral: Behaviour change communication via text message

First Posted Date: 2015-09-28

Last Posted Date: 2016-04-13

Lead Sponsor: Queen's University

Target Recruit Count: 5219

Registration Number: NCT02561624

Locations: 🇹🇿
Pamoja Tunawez, Moshi, Tanzania

Comparability and Standardization of Controlled Allergen Challenge Facilities

Phase 4

Completed

Conditions: Allergic Rhinitis

Interventions: Other: Placebo
Drug: Cetirizine

First Posted Date: 2015-09-07

Last Posted Date: 2019-04-09

Lead Sponsor: Queen's University

Target Recruit Count: 98

Registration Number: NCT02543346

Locations: 🇺🇸
Biogenics Research Chamber, San Antonio, Texas, United States
🇨🇦
Kingston General Hospital, Kingston, Ontario, Canada

Pilot RCT to Test Effectiveness of the ACE4 (Activity Challenge- 4 Areas) for Depression and Anxiety

Not Applicable

Conditions: Anxiety Disorder; Mixed With Depression (Mild)

Interventions: Behavioral: ACE4

First Posted Date: 2015-09-02

Last Posted Date: 2015-09-02

Lead Sponsor: Queen's University

Target Recruit Count: 120

Registration Number: NCT02538549

Locations: 🇨🇦
Addiction & Mental Health Services - Kingston Frontenac Lennox & Addington, Kingston, Ontario, Canada

Durvalumab With or Without Tremelimumab in Advanced Incurable Solid Malignancies Given With or Without Standard Chemotherapy Regimens

Phase 1

Active, not recruiting

Conditions: Solid Malignancies

Interventions: Drug: durvalumab
Drug: tremelimumab

First Posted Date: 2015-09-01

Last Posted Date: 2025-02-17

Lead Sponsor: Canadian Cancer Trials Group

Target Recruit Count: 153

Registration Number: NCT02537418

Locations: 🇨🇦
Tom Baker Cancer Centre, Calgary, Alberta, Canada
🇨🇦
BCCA - Vancouver Cancer Centre, Vancouver, British Columbia, Canada
🇨🇦
Juravinski Cancer Centre at Hamilton Health Sciences, Hamilton, Ontario, Canada

and more 4 locations

RCT of RESOLVE: A Waiting Room Intervention for Crisis Clients

Not Applicable

Conditions: Depression Anxiety Disorder

Interventions: Behavioral: Waiting Room Intervention
Behavioral: Treatment as usual.

First Posted Date: 2015-09-01

Last Posted Date: 2015-09-01

Lead Sponsor: Queen's University

Target Recruit Count: 140

Registration Number: NCT02536924

Locations: 🇨🇦
Addiction & Mental Health Services- Kingston Frontenac Lennox and Addington, Kingston, Ontario, Canada

Action-Based Cognitive Remediation to Improve Vocational Outcomes in Depression

Not Applicable

Completed

Conditions: Depression

Interventions: Behavioral: Cognitive remediation
Behavioral: Action based cognitive remediation

First Posted Date: 2015-08-28

Last Posted Date: 2018-11-14

Lead Sponsor: Queen's University

Target Recruit Count: 73

Registration Number: NCT02535390

Locations: 🇨🇦
Queen's University, Kingston, Ontario, Canada

Wearable Technology for Hospital Inpatients

Completed

Conditions: Heart Rate Monitoring

First Posted Date: 2015-08-19

Last Posted Date: 2016-04-05

Lead Sponsor: Queen's University

Target Recruit Count: 50

Registration Number: NCT02527408

Locations: 🇨🇦
Kingston General Hospital, Kingston, Ontario, Canada

Study Comparing Stereotactic Body Radiotherapy vs Conventional Palliative Radiotherapy (CRT) for Spinal Metastases

Not Applicable

Completed

Conditions: Spinal Metastases

Interventions: Radiation: 20 Gy in 5 fractions

First Posted Date: 2015-07-31

Last Posted Date: 2024-02-13

Lead Sponsor: Canadian Cancer Trials Group

Target Recruit Count: 229

Registration Number: NCT02512965

Locations: 🇦🇺
Auckland City Hospital, Grafton, Aucklund, Australia
🇦🇺
Liverpool Cancer Therapy Centre, Liverpool Hospital, Liverpool, New South Wales, Australia
🇦🇺
Princess Alexandra Hospital, Brisbane, Queensland, Australia

and more 19 locations

Study of Palliative Radiotherapy for Symptomatic Hepatocellular Carcinoma and Liver Metastases

Not Applicable

Completed

Conditions: Hepatocellular Carcinoma
Liver Metastases

Interventions: Other: Best Supportive Care
Radiation: Palliative Radiation Therapy

First Posted Date: 2015-07-30

Last Posted Date: 2024-10-23

Lead Sponsor: Canadian Cancer Trials Group

Target Recruit Count: 66

Registration Number: NCT02511522

Locations: 🇨🇦
Dr. H. Bliss Murphy Cancer Centre, St. John's, Newfoundland and Labrador, Canada
🇨🇦
Royal Victoria Regional Health Centre, Barrie, Ontario, Canada
🇨🇦
Kingston Health Sciences Centre, Kingston, Ontario, Canada

and more 4 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy